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Perfluorinated compounds (PFCs) belong to 
a family of man-made, fluorine-containing 
chemicals that have been manufactured since 
the 1950s. Perfluorooctanoic acid (PFOA) 
and perfluorooctane sulfate (PFOS) are 
two of the most common PFCs. They have 
hydrophobic and lipophobic characteristics 
because the fluorocarbon segment and their 
functional groups (sulfonate or carboxy-
late) can lower surface tension of water. The 
unique properties of PFC compounds make 
them useful in a wide variety of special con-
sumer applications (stain- and water-repellent 
treatments) and industrial applications (sur-
factant and emulsifier). Humans are exposed 
to these chemicals through consumer articles 
(e.g., carpet, furniture, clothing, shampoo, 
cleanser, dental floss), drinking water, food, 
dust, and occupational settings (Guo et al. 
2009; Poulsen et al. 2005; Vestergren and 
Cousins 2009). The widespread presence 
of PFCs and their long biologic half-lives 
for elimination of PFOA and PFOS (range, 
4–5 years) in humans have raised concerns 
about their potential impact on human 
health (Olsen et al. 2007). The most vulner-
able age period is expected to be early in life, 
especially during organogenesis and rapid 
neuron development.
PFOA and PFOS cross the placenta and 
the fetal brain barrier (Butenhoff et al. 2009; 
Cui et al. 2009; Fei et al. 2007). Recent 
experimental evidence suggests that prenatal 
or neonatal exposure to PFOA or PFOS cor-
related with behavioral anomalies in rats or 
mice and delayed neuromotor maturation 
(Butenhoff et al. 2009; Johansson et al. 2008, 
2009), and these behavioral modifications 
appear to persist into adulthood (Johansson 
et al. 2008). It is likely that some of these 
chemicals act through cholinergic or dop-
aminergic mechanisms involving altered 
responses to nicotine or imbalanced expres-
sion of the acetylcholine/dopamine pheno-
type (Johansson et al. 2008; Slotkin et al. 
2008). The alterations in the dopaminergic 
system may be a possible pathophysiologi-
cal cause for attention deficit/hyperactivity 
disorder (ADHD) symptoms (Swanson et al. 
2007). PFCs can also affect protein levels of 
functional importance during neuron growth 
and synaptogenesis (Johansson et al. 2009; 
Liao et al. 2008; Wang et al. 2007).
ADHD and developmental coordination 
disorders (DCDs)—the most common neu-
robehavioral diseases in young children—
have become much more frequently reported 
during the last decades (Pastor and Reuben 
2008). If this is not just related to a change in 
diagnosis, we need to look for other potential 
causes, of which new environmental expo-
sures with increasing levels over time may 
be candidates. The longitudinal design of 
the Danish National Birth Cohort (DNBC) 
provides us with an opportunity to explore 
whether maternal levels of PFOA and PFOS 
early in pregnancy correlate with neurodevel-
opmental anomalies in the offspring. Using 
data from the DNBC, we found that pre-
natal exposure to PFCs was associated with 
reduced fetal growth; but using DNBC data 
on developmental milestones at 6 and 18 
months of age, we found no significant asso-
ciation between in utero exposure to PFOA 
and PFOS and neurologic development (Fei 
et al. 2007, 2008a, 2008b).
In this study, we used two validated ques-
tionnaires [the Strengths and Difficulties 
Questionnaire (SDQ) and the Developmental 
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oB j e c t i v e: Potential neurotoxic effects of perfluorinated compounds (PFCs) have been reported in 
highly exposed animals, but whether these chemicals are neurotoxic in humans is not known. We 
therefore investigated whether prenatal exposure to perfluorooctanoic acid (PFOA) or perfluorooc-
tane sulfate (PFOS), two of the most prevalent PFCs, are associated with behavioral or coordination 
problems in early childhood.
Me t h o d s : We used data from the Danish National Birth Cohort, which enrolled mothers in early 
pregnancy, and we measured maternal blood levels of PFOA and PFOS using specimens drawn 
around 8 weeks of gestation. When the children reached 7 years of age, mothers completed the 
Strengths and Difficulties Questionnaire (SDQ, n = 787) and the Developmental Coordination 
Disorder Questionnaire (DCDQ, n = 526) to assess behavioral health and motor coordination of 
their children. SDQ scores above the 90th percentile were a priori defined to identify behavioral 
problems and DCDQ scores below the 10th percentile were defined as a potential DCD.
re s u l t s: The median concentrations of PFOS and PFOA in maternal blood were 34.4 ng/mL 
[interquartile range (IQR), 26.6–44.5] and 5.4 ng/mL (IQR, 4.0–7.1), respectively, similar to distri-
butions reported for populations without occupational exposure. We found no association between 
higher SDQ scores and maternal levels of PFOS or PFOA, nor did we see any statistically significant 
association with motor coordination disorders.
co n c l u s i o n: The findings suggest that background levels of PFOA and PFOS are not associated 
with behavioral and motor coordination problems in childhood. However, effects on other develop-
mental end points, including cognitive, attentional, and clinical mental disorders not measured in 
this study, cannot be ruled out.
key w o r d s : behavioral problems, child, coordination disorders, maternal blood, neurodevelop-
ment, PFOA, PFOS. Environ Health Perspect 119:573–578 (2011).  doi:10.1289/ehp.1002026 
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Coordination Disorder Questionnaire 
(DCDQ)] to examine the association between 
prenatal exposure to PFOA and PFOS and 
behavioral, social, and motor development of 
children at 7 years of age.
Methods
The detailed designs of the DNBC and the 
PFC study nested in the DNBC have been 
described previously (Fei et al. 2007; Olsen 
et al. 2001). Briefly, the DNBC is a nationwide 
cohort study with prospective data from about 
100,000 pregnancies, with follow-up of the 
children. We took a random sample of 1,400 
women from 43,045 eligible women in the 
cohort who provided a maternal blood sample 
at the first antenatal care visit, gave birth to a 
single live-born child without congenital mal-
formation, and completed all four telephone 
interviews (two during pregnancy and two 
after birth). When the children reached 7 years 
of age, a follow-up interview was conducted in 
2005–2010 using either an online question-
naire or a mailed paper questionnaire.
We assessed behavioral problems using 
the standardized SDQ, which comprised five 
domains (emotional, conduct, hyperactivity, 
peer, and social disorders) (Youth in Mind 
2009). The SDQ is a validated tool to screen 
for hyperactivity and attention problems 
among children (Goodman 1997). Parents, 
mostly mothers, completed a list of 25 ques-
tions that reflected their children’s behavior 
in the previous 6 months. The responses for 
each item were coded as 0 for “not true,” 1 for 
“partly true,” and 2 for “very true.” For each 
of five subscales, scores were summed giving 
a range of 0–10. The scores for the four scales 
(emotional, conduct, hyperactivity, and peer) 
were further summed to generate a total diffi-
culties score ranging from 0 to 40. The proso-
cial score gave a score for positive prosocial 
behavior, and this sum was not included in 
the total difficulties score. If data were miss-
ing but at least three items for a subscale were 
completed, a scale score was prorated (n = 11) 
based on the instructions of SDQ (Youth in 
Mind 2009; scoring instructions available at 
http://www.sdqinfo.com/ScoreSheets/e1.pdf). 
Children having higher scores are more likely 
to have behavioral problems except on the 
prosocial subscale, where low scores indicate 
a problem.
The DCDQ is a parent-reported measure 
developed to assist the identification of DCD 
in children 5–15 years of age (Wilson et al. 
2007). Parents were asked to compare the 
motor performance of their child with that of 
his or her peers using a 5-point Likert scale, 
which provides a measure of a child’s coordi-
nation in everyday functional activities. The 
DCDQ consists of 15 items, and a total score 
range of 15–75. This questionnaire was first 
included in the 7-year follow-up from 2006, 
which explains the number of the children 
with missing data on this outcome.
Plasma concentrations of PFOS and 
PFOA were blindly measured at the 3M 
Toxicology Laboratory (St. Paul, MN) using 
high-performance liquid chromatography/
tandem mass spectrometry. Quality control 
materials (newborn calf serum) were extracted 
using 30 individual solid-phase extractions to 
establish within-run means and SDs for two 
levels of control (15 ng/mL and 44 ng/mL for 
PFOA, 10 ng/mL and 30 ng/mL for PFOS). 
The coefficients of variation for the between-
batch spiked control values were 3.2% and 
3.5% for PFOA and 2.5% and 2.8% for 
PFOS, respectively. The lower limit of quan-
titation (LLOQ) was set at 1.0 ng/mL; val-
ues of PFOA that fell below the LLOQ were 
assigned a value of half the LLOQ. Detailed 
sampling and laboratory methods have been 
published (Fei et al. 2007).
We used logistic regression models in the 
primary analyses. We a priori defined the top 
10% of the children with SDQ data available 
as having a high behavioral problem score. 
The cut points used were as follows: emotional 
symptoms ≥ 4, hyperactivity ≥ 5, conduct 
problems ≥ 3, peer problems ≥ 2, and total 
difficulties ≥ 11, which corresponded to the 
upper 14.3%, 14.2%, 14.6%, 15.2%, 10.4% 
of the respective distributions. Prosocial scores 
< 6 were defined to indicate social problems, 
corresponding to 12.1% of the children. 
Similar to the SDQ data, scores below the 
10th percentile on developmental coordina-
tion (≤ 58) were defined as   potential DCD.
PFOA and PFOS levels were catego-
rized a priori into quartiles, using the low-
est quartile as the reference group. Potential 
confounding variables included in the mod-
els were parity, maternal age, prepregnancy 
body mass index (BMI), smoking and alco-
hol consumption during pregnancy, maternal 
socioeconomic status (SES), sex of the child, 
parental behavioral problem scores during 
their own childhood, breast-feeding, birth 
year, household density, and gestational age 
at blood drawing. Data on breast-feeding 
practices were collected in the interviews at 
6 and 18 months after birth and were cat-
egorized as “never breast-fed or < 3 months,” 
“3–5 months,” and “≥ 6 months” of breast-
feeding. Although breast-feeding practices for 
a child in this study did not directly influ-
ence maternal PFC levels we measured, this 
variable may be correlated with previous 
breast-feeding experience and thus confound 
the associations between PFC exposure and 
behavioral problems of children. 
Household density was defined as the total 
number of rooms divided by the total number 
of persons in the house. Parental behavioral 
problem scores were calculated from the par-
ent’s self-report on their own childhood at the 
7-year interview. (The questionnaire consisted 
of six items and is available at http://www.
ssi.dk.) To avoid loss of the subjects, missing 
values on maternal weight (or height) before 
pregnancy were imputed (n = 9) according 
to maternal height (or weight) before preg-
nancy, maternal age at delivery, parity, socio-
economic status (SES), and birth weight of 
her baby, and prepregnancy BMI was then 
calculated. We assigned the median value 
of alcohol consumption during pregnancy 
(n = 11) or parent’s behavioral scores (n = 10) 
among all the subjects to those with missing 
data on these variables. Analyses were also 
done after excluding those with missing data 
on covariates, and no noteworthy changes 
in the results were seen. We selected poten-
tial confounders based on prior knowledge 
and literature or change-in-estimate principles 
(Maldonado and Greenland 1993). If the 
covariates changed the estimates < 5% when 
taken out of the full model, we removed them 
from the final model. For comparability, all 
scores (total difficulties score and subscales) 
were adjusted for the same set of covariates.
In addition to the dichotomized out-
come analysis described above, we ran linear 
regression for the SDQ and DCD scores after 
data transformation. The values of the SDQ 
subscales and DCD score are skewed, and 
the residuals were not normally distributed 
with any data transformation. Consequently, 
we also categorized these scores into three to 
six subgroups according to the distributions 
and used ordinal logistic regression models 
for these ordinal responses. The proportional 
odds assumption was not violated for any of 
these models.
Written informed consent was obtained 
from all participants at recruitment. We have 
complied with all applicable requirements 
of the U.S. and/Danish regulations, and this 
project was approved by the University of 
California, Los Angeles Office for Protection 
of Research Subjects (06-08-023-01) 
and the Danish Data Protection Agency 
(J.Nr 2006-41-6324).
Results
By October 2009, 787 mothers had com-
pleted the SDQ when their children reached 
the age of 7 years, corresponding to 65% of 
the eligible children whose mothers took part 
in the 7-year data collection (n = 1,282). Of 
these children, 537 completed the DCDQ. 
The mean age of the children at the response 
time was 7.15 years (range, 7.01–8.47). The 
distributions of the SDQ and DCD scores 
are shown in Table 1. The median concentra-
tions of PFOS and PFOA in maternal blood 
were 34.4 ng/mL [interquartile range (IQR), 
26.6–44.5] and 5.4 ng/mL (IQR, 4.0–7.1), 
respectively. Maternal PFOA levels declined 
with increasing parity, higher household Perfluorinated chemicals and child neurodevelopment
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density (fewer rooms per person), longer 
reported duration of breast-feeding, and birth 
year (Table 2). PFOA levels were lower in the 
older mothers (Table 2) but not after adjust-
ment for parity (data not shown). There was a 
positive association between PFOA levels and 
prepregnancy BMI (Table 2), even after tak-
ing into account all predictors of PFC expo-
sure presented in Table 2 (except for parent’s 
behavioral scores during their own childhood) 
(p = 0.05, data not shown). PFOS concentra-
tions were strongly correlated with those of 
PFOA (Spearman’s correlation coefficient, rs = 
0.70 and p < 0.01), and PFOS showed a simi-
lar relationship with those predictors above as 
did PFOA, except that PFOS concentrations 
were statistically significantly lower in women 
of higher SES [see Supplemental Material, 
Table 1 (doi:10.1289/ehp.1002026)].
As shown in Table 3, the prevalence of 
behavioral problems (with a high total dif-
ficulties score) was inversely associated with 
parity and household density after adjustment 
for other covariates. Lower maternal SES 
and parents’ behavioral scores during their 
own childhood were statistically significantly 
associated with behavioral problems of the 
children at 7 years of age. We also observed 
that women who were obese, did not drink 
alcohol, smoked during pregnancy, or had 
breast-fed < 6 months were more likely to 
report a child with a high total difficulties 
score, although all these associations were 
not statistically significant. A high difficulties 
score was more common in boys than girls, 
primarily reflecting differences in the hyper-
activity score. The prevalence of an elevated 
hyperactivity score was 18.3% in boys and 
10.3% in girls.
Tables 4 and 5 show the adjusted asso-
ciations between PFOA and PFOS levels and 
SDQ and DCD scores. The prevalence of 
high scores for total difficulties, emotional 
symptoms, conduct problems, and peer prob-
lems was greater in the fourth quartile of 
PFOA than in the first quartile, but adjusted 
odds ratios (ORs) did not indicate positive 
associations between these outcomes and high 
PFOA exposure. In contrast, women in the 
second or third quartiles of PFOA had sta-
tistically significantly lower odds of having 
a child with higher scores in total difficul-
ties, emotional symptoms, and hyperactive, 
compared with women in the lowest quartile 
(Table 4). We did not observe any association 
between PFOA exposure and prosocial behav-
ior or DCD. For PFOS, there was no clear 
association with behavioral problems in chil-
dren (Table 5), nor did we find any significant 
association between exposure and prosocial 
behavior or DCD. Results from linear regres-
sion and ordinal regression analyses using the 
full scales of behavioral scores also showed no 
significant association with PFOA or PFOS, 
except for an inverse association with prosocial 
behavior scores (which means highly exposed 
women are less likely to report high scores of 
their children) [see Supplemental Material, 
Tables 2 and 3 (doi:10.1289/ehp.1002026)].
Discussion
We found little evidence for an association 
between prenatal exposure to PFOA or PFOS 
and behavioral problems or DCDs in chil-
dren at 7 years of age. The only inverse asso-
ciation between PFCs and prosocial scores 
we observed may be a chance finding. Using 
the same cohort, we had previously reported 
PFOA exposure to be related to lower birth 
weight, birth length, and abdominal circum-
ference (Fei et al. 2007, 2008b).
Reported potential behavioral effects of 
prenatal or neonatal exposure to PFOS and 
PFOA at high doses in rats or mice have been 
abnormal spontaneous behavior, increased 
motor activities, and reduced habituation 
(Butenhoff et al. 2009; Fuentes et al. 2007a; 
Johansson et al. 2008). In contrast, studies in 
adult animals showed PFOS or PFOA expo-
sure had no or only slight neurobehavioral 
effects (Fuentes et al. 2007b; Sato et al. 2009). 
The fetal brain is expected to be particularly 
Table 1. PFOA and PFOS levels in maternal blood and SDQa and DCDQb scores at 7 years of age in the 
DNBC subcohort, 1998–2002.
Exposure and outcomes Mean ± SD Median IQR Range
PFOA (ng/mL) 5.7 ± 2.4 5.4 4.0–7.1 0.5–21.9
PFOS (ng/mL) 36.1 ± 13.1 34.4 26.6–44.5 7.3–106.7
Total difficulties 5.5 ± 4.2 5 3–8 0–25
Emotional symptoms 1.6 ± 1.8 1 0–2 0–9
Hyperactivity 2.2 ± 1.9 2 1–3 0–8
Conduct problems 1.2 ± 1.2 1 0–2 0–7
Peer problems 0.6 ± 1.1 0 0–1 0–7
Prosocial behavior 8.4 ± 1.5 9 8–10 3–10
DCD 67.8 ± 8.1 70 64–74 17–75
an = 787. bn = 537.
Table 2. Characteristics of study subjects according to maternal PFOA levels (ng/mL) in quartiles.
Characteristic < LLOQ–3.95 3.96–5.32 5.35–7.11 7.14–21.90
Maternal age at delivery (years)a,* 31.7 ± 4.1 31.5 ± 4.2 30.4 ± 4.2 29.7 ± 4.4
Prepregnancy BMI (kg/m2)a,b 23.2 ± 3.7 23.7 ± 4.0 23.8 ± 4.4 24.1 ± 4.7
Parent’s behavioral scoresa 6.56 ± 1.56 6.48 ± 1.59 6.46 ± 1.64 6.70 ± 1.51
Gestational week at blood drawing (weeks)a 8.29 ± 2.05 8.16 ± 2.11 7.83 ± 2.12 7.80 ± 2.05
Parity (%)*
0 15.3 35.5 54.8 72.1
1 53.6 41.1 30.5 17.8
≥ 2 31.1 23.4 14.7 10.2
Maternal SES (%)
Higher 55.1 56.4 55.3 47.7
Middle 36.7 37.1 35.0 43.7
Lower 8.2 6.6 9.6 8.6
House density [rooms/person (%)]
< 1 27.6 26.4 22.3 21.8
1 30.1 25.4 34.0 26.4
1–1.5 31.1 28.4 24.4 27.9
≥ 1.5 11.2 19.8 19.3 23.9
Alcohol consumption before pregnancy [drinks/week (%)]b
0 – < 1 54.4 51.0 50.5 61.1
1–1.5 14.0 18.4 15.0 17.1
2–3 19.2 15.3 19.1 15.0
> 3 12.4 15.3 15.5 6.7
Smoking during pregnancy (%) 19.4 23.9 20.3 20.8
Sex of child [male (%)] 51.5 46.7 48.2 50.8
Birth year (%)*
1998 4.1 6.1 9.1 15.2
1999 19.9 24.4 27.9 30.5
2000 31.1 29.4 30.5 26.9
2001 27.6 23.9 23.4 18.3
2002 17.4 16.2 9.1 9.1
Duration of breast-feeding [months (%)]*
< 3 8.7 12.2 15.2 17.3
3–5 10.7 19.8 17.8 24.4
≥ 6 80.6 68.0 67.0 58.4
aMean ± SD. bMissing data: prepregnancy BMI (n = 19); alcohol consumption (n = 11). *p < 0.05 (analysis of variance 
test for maternal age at delivery; chi-square test for parity, birth year, and duration of breast-feeding); p = 0.07 for house 
density (chi-square test).Fei and Olsen
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vulnerable because the blood–brain barrier 
and detoxification capabilities are not yet fully 
developed. PFOS concentrations in fetal rat 
brains were found to be higher than in adult 
maternal brain (Chang et al. 2009), but much 
lower than serum concentrations [approxi-
mately 60–70% lower in the study by Chang 
et al. (2009)]. If PFC exposure has an effect 
on neurodevelopment, in utero exposure or 
exposure in early childhood may cause more 
damage to the nervous system than exposure 
at any other stage of development, and expo-
sure levels during early childhood have been 
found to be higher than in adults (Olsen et al. 
2004). Our previous reports indicated that 
Table 4. ORs for higher SDQ and lower DCD scores at 7 years of age according to maternal PFOA levels (nanograms per milliliter) in quartiles.
< LLOQ–3.95 3.96–5.32 5.35–7.11 7.14–21.90
Outcome n n OR (95% CI) n OR (95% CI) n OR (95% CI) p for trend
Total difficulties (score ≥ 11)a 22 16 0.56 (0.27–1.19) 12 0.36 (0.15–0.82)* 32 0.91 (0.43–1.92) 0.88
Emotional symptoms (score ≥ 4)a 30 17 0.48 (0.24–0.97)* 23 0.70 (0.36–1.38) 43 1.28 (0.66–2.49) 0.21
Hyperactivity (score ≥ 5)a 35 23 0.51 (0.28–0.94)* 20 0.39 (0.20–0.76)* 34 0.62 (0.32–1.19) 0.15
Conduct problems (score ≥ 3)a 26 28 1.12 (0.60–2.07) 27 1.11 (0.58–2.13) 34 1.29 (0.67–2.52) 0.47
Peer problems (score ≥ 2)a 25 31 1.04 (0.56–1.94) 28 1.04 (0.54–2.01) 36 1.01 (0.52–1.99) 0.98
Prosocial behavior (score < 6)a 25 20 0.82 (0.42–1.61) 24 1.05 (0.53–2.06) 25 1.05 (0.51–2.18) 0.75
DCD (≤ 58)b 16 20 1.36 (0.63–2.95) 12 0.73 (0.30–1.81) 16 1.14 (0.46–2.81) 0.89
CI, confidence interval.
aAdjusted for parity, maternal age, prepregnancy BMI, smoking and alcohol consumption during pregnancy, SES, sex of child, breast-feeding, birth year, home density, gestational age 
at blood drawing, parental behavioral problem scores during their childhood. bAdjusted for parity, maternal age, prepregnancy BMI, smoking and alcohol consumption during preg-
nancy, SES, sex of child, breast-feeding, birth year, home density, gestational age at blood drawing. *p < 0.05.
Table 5. ORs for higher SDQ and lower DCD scores at 7 years of age according to maternal PFOS levels (ng/mL) in quartiles.
7.3–26.4 26.6–34.3 34.4–44.3 44.5–106.7
Outcome n n OR (95% CI) n OR (95% CI) n OR (95% CI) p for trend
Total difficulties (score ≥ 11)a 20 23 0.95 (0.47–1.91) 14 0.56 (0.25–1.22) 25 0.92 (0.45–1.87) 0.58
Emotional symptoms (score ≥ 4)a 27 25 0.87 (0.46–1.63) 23 1.02 (0.55–1.92) 31 1.01 (0.54–1.90) 0.83
Hyperactivity (score ≥ 5)a 28 34 1.05 (0.59–1.88) 18 0.51 (0.26–1.00) 32 0.92 (0.50–1.69) 0.39
Conduct problems (score ≥ 3)a 23 34 1.51 (0.82–2.77) 24 0.94 (0.48–1.80) 34 1.45 (0.77–2.72) 0.53
Peer problems (score ≥ 2)a 22 36 1.52 (0.82–2.82) 31 1.33 (0.70–2.53) 31 1.18 (0.62–2.27) 0.83
Prosocial behavior (score < 6)a 21 25 1.22 (0.63–2.33) 22 1.14 (0.58–2.27) 26 1.23 (0.63–2.39) 0.61
DCD (≤ 58)b 17 15 0.77 (0.35–1.71) 12 0.74 (0.32–1.75) 20 1.39 (0.65–3.00) 0.41
CI, confidence interval.
aAdjusted for parity, maternal age, prepregnancy BMI, smoking and alcohol consumption during pregnancy, SES, sex of child, breast-feeding, birth year, home density, gestational age 
at blood drawing, and parental behavioral problem scores during their childhood. bAdjusted for parity, maternal age, prepregnancy BMI, smoking and alcohol consumption during preg-
nancy, SES, sex of child, breast-feeding, birth year, home density, gestational age at blood drawing.
Table 3. Adjusted ORs between predictors of PFCs and a high total difficulties scores (score ≥ 11) at 7 years of age.a
CI, confidence interval.
aAll variables listed in the table above and maternal PFOS concentrations (as a variable of PFC exposure) were put in the model.  *p < 0.05.
Predictor
No. of children 
with score ≥ 11 (%) OR (95% CI)
Maternal age at delivery (years)
< 25 12 (20.3) 1.00 (0.44–2.28)
25–29 36 (11.8) 1.00
30–34 23 (7.9) 0.80 (0.43–1.46)
≥ 35 11 (8.2) 1.00 (0.44–2.27)
Parity
0 47 (13.4) 1.00
1 25 (8.9) 0.66 (0.37–1.20)
≥ 2 10 (6.4) 0.41 (0.17–0.98)*
Prepregnancy BMI (kg/m2)
< 18.5 3 (12.5) 0.74 (0.19–2.95)
18.5–24.9 54 (9.8) 1.00
25.0–29.9 15 (9.9) 0.97 (0.50–1.87)
≥ 30.0 10 (15.6) 1.64 (0.73–3.67)
Alcohol consumption during pregnancy (drinks/week)
Nondrinker 57 (13.2) 1.00
< 1 8 (6.4) 0.60 (0.26–1.33)
1 to < 2 8 (6.0) 0.52 (0.23–1.18)
≥ 2 9 (9.3) 0.99 (0.44–2.23)
Smoking during the pregnancy
No 60 (9.7) 1.00
Yes 22 (13.2) 1.24 (0.69–2.23)
Maternal SES (%)
Higher 35 (8.3) 1.00
Middle 34 (11.3) 1.30 (0.75–2.26)
Lower 13 (20.0) 2.62 (1.19–5.77)*
Predictor
No. of children 
with score ≥ 11 (%) OR (95% CI)
House density (rooms/person)
< 1 28 (14.5) 1.00
1 21 (9.2) 0.61 (0.31–1.18)
1–1.5 14 (6.4) 0.40 (0.20–0.84)*
≥ 2 19 (13.0) 0.76 (0.38–1.52)
Breast-feeding (months)
Never or < 3 16 (15.2) 1.00
3–5 22 (15.4) 1.15 (0.53–2.50)
≥ 6 44 (8.2) 0.72 (0.36–1.45)
Gestational age at blood drawing (weeks) 0.97 (0.87–1.09)
Sex
Girls 37 (9.3) 1.00
Boys 45 (11.6) 1.32 (0.81–2.17)
Birth year
1998 10 (14.7) 1.15 (0.48–2.78)
1999 21 (10.4) 0.83 (0.42–1.65)
2000 19 (8.2) 0.58 (0.29–1.16)
2001 22 (12.0) 1.00
2002 10 (9.8) 0.85 (0.36–2.01)
Parent’s behavioral scores during their own childhood
5 13 (5.5) 1.00
6 14 (6.2) 1.12 (0.50–2.53)
7 21 (13.3) 2.48 (1.16–5.33)*
≥ 8 34 (20.0) 3.79 (1.87–7.70)*Perfluorinated chemicals and child neurodevelopment
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maternal blood level provides a good indica-
tor for the antenatal exposure as measured in 
cord blood (r = 0.74 for PFOS; r = 0.85 for 
PFOA if two outliers were not included) (Fei 
et al. 2007). A more comprehensive assess-
ment of PFC exposure during childhood is of 
importance to fully elucidate the association 
between PFC exposure and child behavior.
The neurotoxic effects observed in animals 
were at doses several orders of magnitude 
higher than those in the general populations. 
For example, Butenhoff et al. (2009) reported 
that the no observed adverse effect and lowest 
observed adverse effect dosages of PFOS were 
0.3 and 1.0 mg/kg-day for development of 
the nervous system in rats, which correspond 
to approximately 6,200 and 27,600 ng/mL 
for the mean maternal serum concentrations, 
respectively (Butenhoff et al. 2009). The 
findings from animal studies may not apply 
to humans because of extremely high doses 
and shorter half-lives of PFOA and PFOS 
in    animals.
The SDQ is a brief screening device for 
identifying high-risk children either in epi-
demiologic research or clinical settings 
(Goodman and Goodman 2009; Koskelainen 
et al. 2000; Wiles et al. 2006), and its reliabil-
ity and validity have been well documented 
(Goodman and Goodman 2009; Obel et al. 
2004). The sensitivity of this score to subtle 
changes in neurodevelopment has also been 
demonstrated in studies of environmental 
exposures such as maternal smoking and alco-
hol drinking (Kelly et al. 2001, 2009; Obel 
et al. 2004). The parents in our study were not 
informed of PFC values in their blood when 
they provided data on their children’s behavior 
over the previous 6 months, and differential 
recall is therefore unlikely. Because of the selec-
tion criteria used for sampling the subcohort 
and loss to follow-up in the 7-year interview, 
the children included in our study appeared to 
be healthier, on average, than the general child 
population. Within the DNBC, the preva-
lence of behavioral problems was around 10% 
(Divan et al. 2008) if the scores were dichoto-
mized as borderline/abnormal according to 
the recommendations of the author of the 
instrument (Goodman 1997); however, the 
prevalence was low (5–6%) when we used the 
same norms to classify the subset of DNBC 
participants included in this study. We used 
the top 10 percentile cutoff criterion based on 
our sample, which was lower than the original 
norms and lower than cut points used in other 
studies (Kelly et al. 2001, 2009). Some chil-
dren with behavior within the normal range 
are possibly misclassified as having behavior 
problems. If PFCs affect only clinical diseases, 
such as ADHD, our study may not be large 
enough to detect such an association.
Using this data source, we were able 
to identify the expected predictors of total 
difficulties score, such as sex of child, par-
ity (a proxy variable of number of siblings), 
prepregnancy BMI, social class, breast-feeding 
experience, smoking during pregnancy, and 
parents’ difficulties scores during childhood 
(Obel et al. 2009; Wiles et al. 2006). We used 
continuous variables or ordinal responses to 
gain more statistical power, but reached simi-
lar conclusions, which indicated that we have 
not overlooked strong associations.
The DNBC is a longitudinal birth cohort 
with extensive data on potential confound-
ers. Still, a protective social environment 
associated with PFC exposure may mask the 
associations, as we can only control for the 
data we have. Approximately 35% of sub-
jects did not complete the 7-year interview 
either because they had not reached 7 years of 
age or because the mothers did not respond. 
Mothers included in this analysis tended to 
be of higher SES, to have been nonsmok-
ers during pregnancy, to have had normal 
prepregnancy BMIs (18.5–24.9 kg/m2), and 
to have breast-fed their child > 6 months [see 
Supplemental Material, Table 4 (doi:10.1289/
ehp.1002026)]. PFOS concentrations of those 
included were systematically higher, because 
PFOS concentrations slightly declined over 
time and younger children were excluded if 
they had not reached 7 years of age before 
this analysis. We adjusted for SES to mini-
mize selection bias. Whether loss to follow-up 
biased the effect measures is not known, but is 
not expected.
In summary, maternal plasma levels of 
PFOA or PFOS measured early in pregnancy 
were not related to behavioral problems or 
DCDs measured by the SDQ and DCDQ 
in the offspring at the age of 7 years. Studies 
using more sensitive indicators of neuropsy-
chological function and including more heav-
ily exposed populations are needed.
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